Synthesis, Structure, and In Vitro Biological Evaluation of Semi-Synthetic Derivatives of Betulin
Source abstract
Abstract
Betulin and α-lipoic acid are naturally occurring substances with different biological properties. Combining two phytochemical units into a conjugate is a frequently used method to obtain new compounds with better pharmacokinetic parameters. This research concerned the preparation of lipoate derivatives of betulin using the Steglich method. Experimental lipophilicity values were determined for target compounds 6–10 by reversed-phase thin-layer chromatography. In silico methods were used to calculate the physicochemical parameters and lipophilicity of new derivatives and to determine the probable directions of biological activity. α-Lipoic acid, betulin, and lipoate derivatives 6–10 were tested for antiproliferative activity against MV4-11, A549, MCF-7, PC-3, HCT116, MiaPaca-2, and Hs294T cancer cells. 3-(5-(1,2-Dithiolan-3-yl)pentanoyl))betulin 10 showed moderate anticancer activity against MV4-11, PC-3, and HCT116, with IC50 values in the range of 39.8–76.7 µM. The introduction of a dithiolate substituent at the C3 position in 28-acetylbetulin gave compound 9 the highest activity (IC50 = 37.9 µM), in the ratio of biphenotypic B myelomonocytic leukemia cells (MV4-11). All lipoate derivatives were inactive towards normal cells.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Natural product bioactivities and synthesis · Natural Antidiabetic Agents Studies · Pharmacological Effects of Natural Compounds
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Organic Chemistry, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia in Katowice, 4 Jagiellońska Str., 41-200 Sosnowiec, Poland
Department of Experimental Oncology, Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Weigla 12, 53-114 Wroclaw, Poland
Funding
Medical University of Silesia
References (54)
Show source-provided references
1. Plant-derived natural products: A source for drug discovery and development10.3390/ddc3010011 ↗
2. Medicinal plants meet modern biodiversity science10.1016/j.cub.2023.12.038 ↗
3. Forni, C., Facchiano, F., Bartoli, M., Pieretti, S., Facchiano, A., D’Arcangelo, D., Norelli, S., Valle, G., Nisini, R., and Beninati, S. (2019). Beneficial role of phytochemicals on oxidative stress and age-related diseases. Biomed. Res. Int., 2019.10.1155/2019/8748253 ↗
4. AlSheikh, H.M.A., Sultan, I., Kumar, V., Rather, I.A., Al-Sheikh, H., Tasleem Jan, A., and Haq, Q.M.R. (2020). Plant-based phytochemicals as possible alternative to antibiotics in combating bacterial drug resistance. Antibiotics, 9.10.3390/antibiotics9080480 ↗
5. An overview of major classes of phytochemicals: Their types and role in disease prevention
6. Phytochemicals: A new arsenal in drug discovery
7. Patra, S., Nayak, R., Patro, S., Pradhan, B., Sahu, B., Behera, C., Bhutia, S.K., and Jena, M. (2021). Chemical diversity of dietary phytochemicals and their mode of chemoprevention. Biotechnol. Rep., 30.10.1016/j.btre.2021.e00633 ↗
8. Potential of nano-phytochemicals in cervical cancer therapy10.1016/j.cca.2020.01.035 ↗
9. Phytochemicals against SARS-CoV as potential drug leads10.1016/j.bj.2020.12.002 ↗
10. Suganya, T., Packiavathy, I.A.S.V., Aseervatham, G.S.B., Carmona, A., Rashmi, V., Mariappan, S., Devi, N.R., and Ananth, D.A. (2022). Tackling multiple-drug-resistant bacteria with conventional and complex phytochemicals. Front. Cell. Infect. Microbiol., 12.10.3389/fcimb.2022.883839 ↗
11. Alam, S., Sarker, M.M.R., Sultana, T.N., Chowdhury, M.N.R., Rashid, M.A., Chaity, N.I., Zhao, C., Xiao, J., Hafez, E.E., and Khan, S.A. (2022). Antidiabetic phytochemicals from medicinal plants: Prospective candidates for new drug discovery and development. Front. Endocrinol., 13.10.3389/fendo.2022.800714 ↗
12. Nisar, A., Jagtap, S., Vyavahare, S., Deshpande, M., Harsulkar, A., Ranjekar, P., and Prakash, O. (2023). Phytochemicals in the treatment of inflammation associated diseases: The journey from preclinical trials to clinical practice. Front. Pharmacol., 14.10.3389/fphar.2023.1177050 ↗
13. Probing the pharmacological binding properties, and reactivity of selective phytochemicals as potential HIV-1 protease inhibitors10.11144/Javeriana.SC24-3.artf ↗
14. Preparation of Conjugates of Cytotoxic Lupane Triterpenes with Biotin10.1021/acs.bioconjchem.5b00567 ↗
15. Natural Products as Sources of New Drugs over the Nearly Four Decades from 01/1981 to 09/201910.1021/acs.jnatprod.9b01285 ↗
16. Choudhari, A.S., Mandave, P.C., Deshpande, M., Ranjekar, P., and Prakash, O. (2020). Phytochemicals in cancer treatment: From preclinical studies to clinical practice. Front. Pharmacol., 10.10.3389/fphar.2019.01614 ↗
17. Silymarin, an antioxidant flavonoid, protects the liver from the toxicity of the anticancer drug paclitaxel10.1016/j.tice.2023.102158 ↗
18. Demets, O.V., Takibayeva, A.T., Kassenov, R.Z., and Aliyeva, M.R. (2022). Methods of betulin extraction from birch bark. Molecules, 27.10.3390/molecules27113621 ↗
19. Adepoju, F.O., Duru, K.C., Li, E., Kovaleva, E.G., and Tsurkan, M.V. (2023). Pharmacological potential of betulin as a multitarget compound. Biomolecules, 13.10.3390/biom13071105 ↗
20. Amiri, S., Dastghaib, S., Ahmadi, M., Mehrbod, P., Khadem, F., Behrouj, H., Aghanoori, M.R., Machaj, F., Ghamsari, M., and Rosik, J. (2020). Betulin and its derivatives as novel compounds with different pharmacological effects. Biotech. Adv., 38.10.1016/j.biotechadv.2019.06.008 ↗
21. Betulin and betulinic acid: Triterpenoids derivatives with a powerful biological potential10.1007/s11101-019-09623-1 ↗
22. Review of lipoic acid: From a clinical therapeutic agent to various emerging biomaterials10.1016/j.ijpharm.2022.122201 ↗
23. Salehi, B., Berkay Yılmaz, Y., Antika, G., Boyunegmez Tumer, T., Fawzi Mahomoodally, M., Lobine, D., Akram, M., Riaz, M., Capanoglu, E., and Sharopov, F. (2019). Insights on the use of α-lipoic acid for therapeutic purposes. Biomolecules, 9.10.3390/biom9080356 ↗
24. Biochemical and clinical relevance of alpha lipoic acid: Antioxidant and anti-inflammatory activity, molecular pathways and therapeutic potential10.1007/s00011-017-1079-6 ↗
25. The disulfide compound α-lipoic acid and its derivatives: A novel class of anticancer agents targeting mitochondria10.1016/j.canlet.2015.11.019 ↗
26. Combination of alpha-lipoic acid and auraptene induces apoptosis and prevents proliferation of the human U-87 glioblastoma cells10.1007/s43450-023-00440-4 ↗
27. Liu, X., Barth, M.C., Cseh, K., Kowol, C.R., Jakupec, M.A., Keppler, B.K., Gibson, D., and Weigand, W. (2022). Oxoplatin-based Pt(IV) lipoate complexes and their biological activity. Chem. Biodivers., 19.10.1002/cbdv.202200695 ↗
28. Preparation of a 24-nor-1,4-dien-3-one triterpene derivative from betulin: A new route to 24-nortriterpene analogues10.1021/jo010929h ↗
29. Chrobak, E., Marciniec, K., Dąbrowska, A., Pęcak, P., Bębenek, E., Kadela-Tomanek, M., Bak, A., Jastrzębska, M., and Boryczka, S. (2019). New phosphorus analogs of bevirimat: Synthesis, evaluation of anti-HIV-1 activity and molecular docking study. Int. J. Mol. Sci., 20.10.3390/ijms20205209 ↗
30. Colorado potato beetle antifeedants by simple modification of the birchbark triterpene betulin10.1021/jf00057a035 ↗
31. Betulin-derived compounds as inhibitors of alphavirus replication10.1021/np9003245 ↗
32. Synthesis of [13C]- and [2H] betulin for biological transformations10.1002/jlac.1991199101215 ↗
33. Pęcak, P., Świtalska, M., Chrobak, E., Boryczka, G., and Bębenek, E. (2023). Betulin acid ester derivatives inhibit cancer cell growth by inducing apoptosis through caspase cascade activation: A comprehensive in vitro and in silico study. Int. J. Mol. Sci., 24.10.3390/ijms24010196 ↗
34. Application of associative neural networks for prediction of lipophilicity in ALOGPS 2.1 program10.1021/ci025515j ↗
35. Daina, A., Michielin, O., and Zoete, V. (2017). SwissADME: A free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci. Rep., 7.10.1038/srep42717 ↗
36. PASS: Prediction of activity spectra for biologically active substances10.1093/bioinformatics/16.8.747 ↗
37. Czarnecka, M., Świtalska, M., Wietrzyk, J., Maciejewska, G., and Gliszczyńska, A. (2018). Synthesis, characterization, and in vitro cancer cell growth inhibition evaluation of novel phosphatidylcholines with anisic and veratric acids. Molecules, 23.10.3390/molecules23082022 ↗
38. Šiman, P., Filipová, A., Tichá, A., Niang, M., Bezrouk, A., and Havelek, R. (2016). Effective method of purification of betulin from birch bark: The importance of its purity for scientific and medicinal use. PLoS ONE, 11.10.1371/journal.pone.0154933 ↗
39. Synthesis of phthalates of betulinic acid and betulin with cytotoxic activity10.1016/j.bmc.2005.03.006 ↗
40. Lipophilic Efficiency as an Important Metric in Drug Design10.1021/acs.jmedchem.8b00077 ↗
41. Theoretical and experimental study on lipophilicity and wound healing activity of ginger compounds10.12980/APJTB.4.2014C1012 ↗
42. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings10.1016/S0169-409X(00)00129-0 ↗
43. A drug-likeness toolbox facilitates ADMET study in drug discovery10.1016/j.drudis.2019.10.014 ↗
44. Success stories of natural product-based hybrid molecules for multi-factorial diseases10.1016/j.ejmech.2018.03.057 ↗
45. Synthesis and anticancer effects of α-lipoic ester of alloxanthoxyletin10.1007/s00044-019-02335-3 ↗
46. Bioconjugation of cyclometalated gold(III) lipoic acid fragments to linear and cyclic breast cancer targeting peptides10.1021/acs.molpharmaceut.9b00695 ↗
47. Synthesis of oleanolic acid/ursolic acid/glycyrrhetinic acid-hydrogen sulfide donor hybrids and their antitumor activity10.1007/s00044-019-02366-w ↗
48. Pfeffer, C.M., and Singh, A.T.K. (2018). Apoptosis: A target for anticancer therapy. Int. J. Mol. Sci., 19.10.3390/ijms19020448 ↗
49. Synthesis and in vitro antitumor evaluation of betulin acid ester derivatives as novel apoptosis inducers10.1016/j.ejmech.2015.08.004 ↗
50. Wang, J., Wu, J., Han, Y., Zhang, J., Lin, Y., Wang, H., Wang, J., Liu, J., and Bu, M. (2021). Design and synthesis of novel betulin derivatives containing thio-/semicarbazone moieties as apoptotic inducers through mitochindria-related pathways. Molecules, 26.10.3390/molecules26216356 ↗
51. Mihoub, M., Pichette, A., Sylla, B., Gauthier, C., and Legault, J. (2018). Bidesmosidic betulin saponin bearing L-rhamnopyranoside moieties induces apoptosis and inhibition of lung cancer cells growth in vitro and in vivo. PLoS ONE, 13.10.1371/journal.pone.0193386 ↗
52. The anti-cancer effect of betulinic acid in u937 human leukemia cells is mediated through ROS-dependent cell cycle arrest and apoptosis10.1080/19768354.2021.1915380 ↗
53. Tuli, H.S., Sak, K., Gupta, D.S., Kaur, G., Aggarwal, D., Chaturvedi Parashar, N., Choudhary, R., Yerer, M.B., Kaur, J., and Kumar, M. (2021). Anti-inflammatory and anticancer properties of birch bark-derived betulin: Recent developments. Plants, 10.10.3390/plants10122663 ↗
54. Betulin terpenoid targets OVCAR-3 human ovarian carcinoma cells by inducing mitochondrial mediated apoptosis, G2/M phase cell cycle arrest, inhibition of cell migration and invasion and modulating mTOR/PI3K/AKT signalling pathway10.14715/cmb/2021.67.2.3 ↗